Latest Compliance News

Gullewa Limited reported a robust cash flow position for the December 2025 quarter, driven by a significant equity financing that bolstered its cash reserves to over A$9 million. The company continues to invest in its iron ore exploration projects while maintaining operational cash flow positivity.

Critica Limited has addressed a recent spike in its share price and trading volume, attributing the movement to positive research coverage while confirming no undisclosed information is driving the activity.

Epsilon Healthcare has posted a record $2.891 million in receipts for the December 2025 quarter, nearly doubling year-on-year revenue and marking a significant turnaround with its recent ASX reinstatement.

Aeeris Ltd has reported a profitable second quarter for FY26, with total unadjusted revenue rising 61% year-on-year to $1.54 million and annual recurring revenue climbing 16.5% to nearly $4 million. The company’s operational advances and disciplined cost control underpin a promising path to sustainable profitability.

Element 25 Limited has made significant strides in advancing its Butcherbird Expansion Project in Western Australia, securing $60 million in funding and progressing key engineering and contract milestones. Simultaneously, the company moves closer to finalising financing for its US-based battery-grade manganese refinery.

Albright Metals has released initial assay results from its 2025 drilling campaign at the Vail Road Gold Deposit, revealing impressive high-grade gold intercepts that validate previous data and underpin plans for resource estimation.

Boss Energy Limited reported a robust quarterly cash flow for December 2025, ending with nearly A$53 million in unrestricted cash and positive operating inflows. The company maintained steady investment in exploration and infrastructure while keeping financing activities minimal.

GBM Resources has reported a successful Stage 1 drilling campaign at its Twin Hills gold project in Queensland, revealing significant high-grade gold mineralisation beyond existing resources. The company also advanced its portfolio strategy by divesting non-core assets and securing a substantial capital raise.

Develop Global Limited reported a positive operating cash flow of AUD 18.8 million for the December 2025 quarter, maintaining robust liquidity despite significant investing and financing cash outflows.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Clever Culture Systems has expanded its APAS Independence installed base to 27 instruments globally and surpassed $1 million in annual recurring revenue, underpinned by strong sales momentum and customer validation.

Argenica Therapeutics has unveiled compelling AI-driven results confirming ARG-007’s significant benefits in severe acute ischemic stroke patients, setting the stage for a precision-focused Phase 2b trial.